Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linezolid for MRSA infections in Japan (Salvage Therapy)
NCT00150332Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of linezolid in Staphylococcus aureus infection, sponsored by Pfizer. Started Jan 2003; status: completed.
02
Drugs
linezolid
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT00150332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150332.